US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Exelixis

41.75

+0.68001.66%

Volume:654.14K

Turnover:27.38M

Market Cap:10.84B

PE:15.02

High:42.13

Open:41.36

Low:41.24

Close:41.07

52wk High:49.62

52wk Low:32.38

Shares:259.71M

Float Shares:223.00M

Volume Ratio:0.58

T/O Rate:0.29%

Dividend:- -

Dividend Rate:- -

EPS(TTM):2.78

EPS(LYR):2.78

ROE:35.53%

ROA:19.27%

PB:5.02

PE(LYR):15.02

Loading ...

Overview Company News Filings

Exelixis forecasts 2026 net product revenues of $2.325 billion to $2.425 billion

Exelixis Inc: Fiscal Year 2026 Net Product Revenues Guidance of $2.325 Billion - $2.425 Billion

THOMSON REUTERS

A Look At Exelixis (EXEL) Valuation After Zanzalintinib Phase 3 Success And New STELLAR-316 Trial

Simply Wall St.

Signet Jewelers, Natural Gas Services, and More Stocks See Action From Activist Investors -- Barrons.com

Exelixis Shares Fall After Downgrade From Morgan Stanley

MT Newswires Live

Exelixis Is Maintained at Buy by HC Wainwright & Co.

Exelixis price target raised to $52 from $49 at H.C. Wainwright

Exelixis, Inc. : H.c. Wainwright Raises Target Price to $52 From $49

THOMSON REUTERS

Morgan Stanley Downgrades Exelixis to Equalweight, Price Target is $48

MT Newswires Live

Exelixis Cut to Equal-Weight From Overweight by Morgan Stanley

BRIEF-Exelixis And Natera To Collaborate On Stellar-316, A Phase 3 Pivotal Trial Of Zanzalintinib

Exelixis and Natera Announce Collaboration on Phase 3 Colorectal Cancer Trial

Exelixis Inc - Expects to Initiate Stellar-316 in Mid-2026

THOMSON REUTERS

Exelixis and Natera to Collaborate on Stellar-316, a Phase 3 Pivotal Trial of Zanzalintinib for Patients With Colorectal Cancer

THOMSON REUTERS

Exelixis CEO to Present Corporate Overview at J.P. Morgan Healthcare Conference

Exelixis Faces Limited High-Impact Catalysts, BofA Says

MT Newswires Live

BofA Securities Downgrades Exelixis to Underperform From Neutral, Adjusts Price Target to $41 From $43

MT Newswires Live

Exelixis Webcasts Virtual 2025 R&D Day to Showcase Oncology Strategy

Exelixis director buys $1.2M in common stock

Exelixis Inc. Director David Edward Johnson Reports Acquisition of Common Shares

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/EXEL/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"EXEL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EXEL\",,,,,undefined,":{"symbol":"EXEL","market":"US","secType":"STK","nameCN":"Exelixis","latestPrice":41.75,"timestamp":1773763751466,"preClose":41.07,"halted":0,"volume":654141,"delay":0,"changeRate":0.01655709763817871,"floatShares":223000000,"shares":259708689,"eps":2.78,"marketStatus":"Trading","change":0.68,"latestTime":"03-17 12:09:13 EDT","open":41.36,"high":42.13,"low":41.24,"amount":27375273.612354,"amplitude":0.02167,"askPrice":41.75,"askSize":8,"bidPrice":41.73,"bidSize":300,"shortable":3,"etf":0,"ttmEps":2.78,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1773777600000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":955425600000,"exchange":"NASDAQ","adjPreClose":41.07,"preHourTrading":{"tag":"盘前","latestPrice":41.28,"preClose":41.07,"latestTime":"09:29 EDT","volume":2089,"amount":85927.791673,"timestamp":1773754199999,"change":0.21,"changeRate":0.005113,"amplitude":0.034575},"postHourTrading":{"tag":"盘后","latestPrice":41.07,"preClose":41.07,"latestTime":"18:21 EDT","volume":39152,"amount":1607973.12,"timestamp":1773699688071,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.584749,"impliedVol":0.3419,"impliedVolPercentile":0.3586},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EXEL\",,,,,undefined,":{"symbol":"EXEL","floatShares":223000000,"roa":"19.27%","roe":"35.53%","lyrEps":2.78,"volumeRatio":0.584749,"shares":259708689,"dividePrice":0,"high":42.13,"amplitude":0.02167,"preClose":41.07,"low":41.24,"week52Low":32.38,"pbRate":"5.02","psRate":"4.67","week52High":49.62,"institutionHeld":0.8369,"latestPrice":41.75,"committee":0.948052,"eps":2.78,"divideRate":0,"volume":654141,"delay":0,"ttmEps":2.78,"open":41.36,"prevYearClose":43.83,"prevWeekClose":41.24,"prevMonthClose":44.06,"prevQuarterClose":43.83,"fiveDayClose":41.29,"twentyDayClose":44.08,"sixtyDayClose":42},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/EXEL\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-02-10","symbol":"EXEL","fiscalQuarterEnding":"2025/12","expectedEps":0.68,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1770699600000,"reportTimeType":"post","actualEps":0.48},{"market":"US","date":"2026-01-11","symbol":"EXEL","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1768107600000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-11-04","symbol":"EXEL","fiscalQuarterEnding":"2025/09","expectedEps":0.59,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1762232400000,"reportTimeType":"post","actualEps":0.67},{"market":"US","date":"2025-07-28","symbol":"EXEL","fiscalQuarterEnding":"2025/06","expectedEps":0.58,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1753675200000,"reportTimeType":"post","actualEps":0.65},{"market":"US","date":"2025-05-13","symbol":"EXEL","fiscalQuarterEnding":"2025/03","expectedEps":0.35,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747108800000,"reportTimeType":"post","actualEps":0.53}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"EXEL\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"EXEL\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1905,"buy":0.2857,"hold":0.4762,"sell":0.0476,"strongSell":0,"meanLabel":"BUY","meanPercent":0.2857,"analysts":21,"updateTime":1768104000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/EXEL\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"EXEL","date":"2026-03-16","current":14.773381,"percent":0.002431,"low":13.520237,"twenty":18.397459,"median":29.434352,"eighty":42.231595,"high":123.671097,"avg":35.212698,"sd":22.845362,"marketCap":10710386334},"quantilePoints":[{"date":"2021-03-19","current":65.311261,"twenty":-27.329077,"median":9.710451,"eighty":25.161223,"marketCap":7300558067},{"date":"2021-03-26","current":63.329595,"twenty":-27.325861,"median":9.736947,"eighty":25.234082,"marketCap":7079045408},{"date":"2021-04-01","current":64.529759,"twenty":-27.325861,"median":9.747742,"eighty":25.270502,"marketCap":7213200962},{"date":"2021-04-09","current":64.529759,"twenty":-27.329077,"median":9.805299,"eighty":25.357929,"marketCap":7213200962},{"date":"2021-04-16","current":66.075436,"twenty":-27.329077,"median":9.834498,"eighty":25.412148,"marketCap":7385978281},{"date":"2021-04-23","current":69.268568,"twenty":-27.329077,"median":9.92067,"eighty":25.491815,"marketCap":7742909830},{"date":"2021-04-30","current":68.960459,"twenty":-27.329077,"median":9.944579,"eighty":25.677015,"marketCap":7708469067},{"date":"2021-05-07","current":121.493789,"twenty":-27.329077,"median":9.977077,"eighty":25.790166,"marketCap":7869152717},{"date":"2021-05-14","current":123.671097,"twenty":-27.329077,"median":10.042797,"eighty":25.900353,"marketCap":8010176959},{"date":"2021-05-21","current":118.348789,"twenty":-27.329077,"median":10.090291,"eighty":26.029567,"marketCap":7665451034},{"date":"2021-05-28","current":109.107325,"twenty":-27.329077,"median":10.142137,"eighty":26.116578,"marketCap":7066881472},{"date":"2021-06-04","current":108.236402,"twenty":-27.329077,"median":10.259913,"eighty":26.305665,"marketCap":7010471775},{"date":"2021-06-11","current":111.187864,"twenty":-27.329077,"median":10.30588,"eighty":26.528137,"marketCap":7201637970},{"date":"2021-06-18","current":108.429941,"twenty":-27.329077,"median":10.499122,"eighty":26.899667,"marketCap":7023007264},{"date":"2021-06-25","current":113.316788,"twenty":-27.329077,"median":10.577409,"eighty":27.427848,"marketCap":7339528341},{"date":"2021-07-02","current":88.350322,"twenty":-27.329077,"median":10.668743,"eighty":28.437015,"marketCap":5722450363},{"date":"2021-07-09","current":87.140707,"twenty":-27.329077,"median":10.768777,"eighty":32.735526,"marketCap":5644103562},{"date":"2021-07-16","current":81.286167,"twenty":-27.329077,"median":12.586346,"eighty":38.333898,"marketCap":5264905044},{"date":"2021-07-23","current":80.947475,"twenty":-27.329077,"median":13.259462,"eighty":38.843712,"marketCap":5242967939},{"date":"2021-07-30","current":81.52809,"twenty":-27.329077,"median":13.665176,"eighty":39.250255,"marketCap":5280574404},{"date":"2021-08-06","current":57.789598,"twenty":-27.329077,"median":14.041856,"eighty":39.491398,"marketCap":5434591593},{"date":"2021-08-13","current":61.240223,"twenty":-27.329077,"median":14.246084,"eighty":40.05544,"marketCap":5759091844},{"date":"2021-08-20","current":61.776243,"twenty":-27.329077,"median":14.431907,"eighty":40.44398,"marketCap":5809499650},{"date":"2021-08-27","current":65.092863,"twenty":-27.329077,"median":14.633356,"eighty":40.76874,"marketCap":6121397950},{"date":"2021-09-03","current":66.231905,"twenty":-27.329077,"median":14.930088,"eighty":41.024831,"marketCap":6228514538},{"date":"2021-09-10","current":66.868428,"twenty":-27.329077,"median":15.002715,"eighty":41.184268,"marketCap":6288373808},{"date":"2021-09-17","current":69.41452,"twenty":-27.329077,"median":15.270884,"eighty":41.645802,"marketCap":6527810887},{"date":"2021-09-24","current":68.174975,"twenty":-27.329077,"median":15.454005,"eighty":42.220717,"marketCap":6411242835},{"date":"2021-10-01","current":72.16162,"twenty":-27.329077,"median":15.627908,"eighty":42.663031,"marketCap":6786150893},{"date":"2021-10-08","current":72.42963,"twenty":-27.329077,"median":15.773963,"eighty":43.366777,"marketCap":6811354796},{"date":"2021-10-15","current":73.099654,"twenty":-27.329077,"median":15.952475,"eighty":44.822559,"marketCap":6874364554},{"date":"2021-10-22","current":71.692603,"twenty":-27.329077,"median":16.00116,"eighty":45.312226,"marketCap":6742044063},{"date":"2021-10-29","current":72.061116,"twenty":-27.329077,"median":16.265432,"eighty":45.826118,"marketCap":6776699429},{"date":"2021-11-05","current":37.285528,"twenty":-27.329077,"median":16.391679,"eighty":45.919924,"marketCap":6125452889},{"date":"2021-11-12","current":34.858887,"twenty":-27.329077,"median":16.479897,"eighty":45.919924,"marketCap":5726792216},{"date":"2021-11-19","current":34.724073,"twenty":-27.329077,"median":16.682751,"eighty":45.919924,"marketCap":5704644400},{"date":"2021-11-26","current":32.855945,"twenty":-27.200425,"median":16.81027,"eighty":45.919924,"marketCap":5397738961},{"date":"2021-12-03","current":30.506341,"twenty":-26.943119,"median":16.933764,"eighty":45.919924,"marketCap":5011734182},{"date":"2021-12-10","current":32.066324,"twenty":-26.245177,"median":17.104522,"eighty":45.919924,"marketCap":5268016044},{"date":"2021-12-17","current":35.051477,"twenty":-24.694911,"median":17.218287,"eighty":45.919924,"marketCap":5758431952},{"date":"2021-12-23","current":37.131455,"twenty":-24.254275,"median":17.32582,"eighty":45.919924,"marketCap":6100141100},{"date":"2021-12-31","current":35.20555,"twenty":7.517288,"median":17.464132,"eighty":45.919924,"marketCap":5783743740},{"date":"2022-01-07","current":36.091466,"twenty":7.709485,"median":17.687208,"eighty":45.891374,"marketCap":5929286526},{"date":"2022-01-14","current":34.897405,"twenty":7.799575,"median":17.756166,"eighty":45.891374,"marketCap":5733120163},{"date":"2022-01-21","current":33.356681,"twenty":7.907699,"median":17.862859,"eighty":45.891374,"marketCap":5480002275},{"date":"2022-01-28","current":34.223338,"twenty":7.943549,"median":18.081923,"eighty":45.891374,"marketCap":5622381087},{"date":"2022-02-04","current":36.187761,"twenty":8.039903,"median":18.360975,"eighty":45.891374,"marketCap":5945106394},{"date":"2022-02-11","current":36.110725,"twenty":8.136529,"median":18.515656,"eighty":45.891374,"marketCap":5932450500},{"date":"2022-02-18","current":27.042003,"twenty":8.217909,"median":18.789229,"eighty":45.891374,"marketCap":6248406283},{"date":"2022-02-25","current":27.899162,"twenty":8.270506,"median":18.897922,"eighty":45.891374,"marketCap":6446464151},{"date":"2022-03-04","current":28.61807,"twenty":8.371042,"median":19.106053,"eighty":45.891374,"marketCap":6612577201},{"date":"2022-03-11","current":29.019,"twenty":8.507031,"median":19.335948,"eighty":45.891374,"marketCap":6705217172},{"date":"2022-03-18","current":29.572006,"twenty":8.621808,"median":21.199768,"eighty":45.891374,"marketCap":6832996441},{"date":"2022-03-25","current":30.249439,"twenty":8.73225,"median":22.506564,"eighty":45.891374,"marketCap":6989526047},{"date":"2022-04-01","current":31.645779,"twenty":8.756029,"median":22.697854,"eighty":45.891374,"marketCap":7312168702},{"date":"2022-04-08","current":31.825506,"twenty":8.792498,"median":22.852188,"eighty":45.891374,"marketCap":7353696965},{"date":"2022-04-14","current":31.995647,"twenty":8.865935,"median":22.952956,"eighty":45.891374,"marketCap":7393010230},{"date":"2022-04-22","current":31.067233,"twenty":8.939729,"median":23.213643,"eighty":45.891374,"marketCap":7178488062},{"date":"2022-04-29","current":30.956378,"twenty":8.974263,"median":23.420305,"eighty":45.891374,"marketCap":7152873475},{"date":"2022-05-06","current":29.778539,"twenty":9.039592,"median":23.531551,"eighty":45.891374,"marketCap":6880718486},{"date":"2022-05-13","current":21.60979,"twenty":9.09473,"median":23.549925,"eighty":45.891374,"marketCap":6440473677},{"date":"2022-05-20","current":19.113041,"twenty":9.107191,"median":23.549925,"eighty":45.891374,"marketCap":5696355204},{"date":"2022-05-27","current":19.801799,"twenty":9.125872,"median":23.549925,"eighty":45.891374,"marketCap":5901629266},{"date":"2022-06-03","current":20.490558,"twenty":9.145972,"median":23.549925,"eighty":45.891374,"marketCap":6106903327},{"date":"2022-06-10","current":19.521991,"twenty":9.183299,"median":23.549925,"eighty":45.891374,"marketCap":5818236678},{"date":"2022-06-17","current":19.973989,"twenty":9.197529,"median":23.549925,"eighty":45.891374,"marketCap":5952947781},{"date":"2022-06-24","current":23.912825,"twenty":9.237499,"median":23.564333,"eighty":45.919924,"marketCap":7126858820},{"date":"2022-07-01","current":23.213305,"twenty":9.247736,"median":23.584442,"eighty":45.919924,"marketCap":6918377351},{"date":"2022-07-08","current":23.686826,"twenty":9.281845,"median":23.611294,"eighty":45.919924,"marketCap":7059503269},{"date":"2022-07-15","current":22.965782,"twenty":9.328108,"median":23.611294,"eighty":45.919924,"marketCap":6844606986},{"date":"2022-07-22","current":22.449214,"twenty":9.353834,"median":23.633017,"eighty":45.919924,"marketCap":6690651440},{"date":"2022-07-29","current":22.513785,"twenty":9.38718,"median":23.633017,"eighty":45.919924,"marketCap":6709895883},{"date":"2022-08-05","current":23.159496,"twenty":9.423477,"median":23.633017,"eighty":45.919924,"marketCap":6902340315},{"date":"2022-08-12","current":22.996839,"twenty":9.477679,"median":23.677084,"eighty":45.919924,"marketCap":6269283152},{"date":"2022-08-19","current":22.819758,"twenty":9.532448,"median":23.677084,"eighty":45.919924,"marketCap":6221008384},{"date":"2022-08-26","current":21.521169,"twenty":9.589879,"median":23.677084,"eighty":45.919924,"marketCap":5866993422},{"date":"2022-09-02","current":21.143397,"twenty":9.637235,"median":23.677084,"eighty":45.919924,"marketCap":5764007251},{"date":"2022-09-09","current":21.131592,"twenty":9.656291,"median":23.677084,"eighty":45.919924,"marketCap":5760788933},{"date":"2022-09-16","current":20.24619,"twenty":9.709392,"median":23.677084,"eighty":45.919924,"marketCap":5519415095},{"date":"2022-09-23","current":19.219124,"twenty":9.737158,"median":23.677084,"eighty":45.919924,"marketCap":5239421443},{"date":"2022-09-30","current":18.510802,"twenty":9.752596,"median":23.677084,"eighty":45.919924,"marketCap":5046322373},{"date":"2022-10-07","current":18.180252,"twenty":9.809283,"median":23.677084,"eighty":45.919924,"marketCap":4956209473},{"date":"2022-10-14","current":18.475386,"twenty":9.839263,"median":23.677084,"eighty":45.919924,"marketCap":5036667419},{"date":"2022-10-21","current":19.419815,"twenty":9.921087,"median":23.677084,"eighty":45.919924,"marketCap":5294132846},{"date":"2022-10-28","current":19.632311,"twenty":9.95111,"median":23.677084,"eighty":45.919924,"marketCap":5352062567},{"date":"2022-11-04","current":17.259423,"twenty":9.977849,"median":23.677084,"eighty":45.919924,"marketCap":5309360940},{"date":"2022-11-11","current":17.615936,"twenty":10.045835,"median":23.677084,"eighty":45.919924,"marketCap":5419031822},{"date":"2022-11-18","current":17.731278,"twenty":10.09551,"median":23.677084,"eighty":45.919924,"marketCap":5454513578},{"date":"2022-11-25","current":17.762735,"twenty":10.137764,"median":23.677084,"eighty":45.919924,"marketCap":5464190420},{"date":"2022-12-02","current":18.234591,"twenty":10.262522,"median":23.677084,"eighty":45.919924,"marketCap":5609343059},{"date":"2022-12-09","current":16.535911,"twenty":10.306552,"median":23.677084,"eighty":45.919924,"marketCap":5086793561},{"date":"2022-12-16","current":16.714168,"twenty":10.501618,"median":23.677084,"eighty":45.919924,"marketCap":5141629002},{"date":"2022-12-23","current":16.598825,"twenty":10.590509,"median":23.677084,"eighty":45.919924,"marketCap":5106147246},{"date":"2022-12-30","current":16.819025,"twenty":10.667114,"median":23.677084,"eighty":45.919924,"marketCap":5173885144},{"date":"2023-01-06","current":18.108763,"twenty":10.667114,"median":23.584442,"eighty":45.49168,"marketCap":5570635688},{"date":"2023-01-13","current":17.227966,"twenty":10.667114,"median":23.503875,"eighty":45.1654,"marketCap":5299684097},{"date":"2023-01-20","current":17.542536,"twenty":10.667114,"median":23.449537,"eighty":44.010071,"marketCap":5396452523},{"date":"2023-01-27","current":18.318476,"twenty":10.667114,"median":23.314972,"eighty":43.020435,"marketCap":5635147972},{"date":"2023-02-03","current":18.402362,"twenty":10.667114,"median":23.194326,"eighty":42.458135,"marketCap":5660952885},{"date":"2023-02-10","current":31.202932,"twenty":10.667114,"median":23.191781,"eighty":42.011762,"marketCap":5687732764},{"date":"2023-02-17","current":31.096255,"twenty":10.667114,"median":23.191781,"eighty":41.420955,"marketCap":5668287524},{"date":"2023-02-24","current":30.456195,"twenty":10.667114,"median":23.191781,"eighty":41.184268,"marketCap":5551616082},{"date":"2023-03-03","current":30.491754,"twenty":10.667114,"median":23.191781,"eighty":40.984929,"marketCap":5558097829},{"date":"2023-03-10","current":29.65612,"twenty":10.667114,"median":23.191781,"eighty":40.686627,"marketCap":5405776781},{"date":"2023-03-17","current":31.202932,"twenty":10.667114,"median":23.191781,"eighty":40.243946,"marketCap":5687732764},{"date":"2023-03-24","current":32.85642,"twenty":10.667114,"median":23.191781,"eighty":39.955417,"marketCap":5989133987},{"date":"2023-03-31","current":34.509909,"twenty":10.667928,"median":23.193053,"eighty":39.475483,"marketCap":6290535211},{"date":"2023-04-06","current":35.363322,"twenty":10.667928,"median":23.193053,"eighty":39.271956,"marketCap":6446097132},{"date":"2023-04-14","current":34.918836,"twenty":10.667114,"median":23.191781,"eighty":39.023166,"marketCap":6365075298},{"date":"2023-04-21","current":33.620936,"twenty":10.667114,"median":23.191781,"eighty":38.427704,"marketCap":6128491542},{"date":"2023-04-28","current":32.305257,"twenty":10.667114,"median":23.191781,"eighty":37.395181,"marketCap":5888666913},{"date":"2023-05-05","current":34.73643,"twenty":10.667114,"median":23.191781,"eighty":37.193084,"marketCap":6331825854},{"date":"2023-05-12","current":40.911234,"twenty":10.667114,"median":23.213305,"eighty":37.526354,"marketCap":6289570343},{"date":"2023-05-19","current":41.790934,"twenty":10.666299,"median":23.203815,"eighty":38.431783,"marketCap":6424812840},{"date":"2023-05-26","current":40.308235,"twenty":10.666299,"median":23.203815,"eighty":39.03948,"marketCap":6196867124},{"date":"2023-05-31","current":40.265872,"twenty":10.666299,"median":23.203815,"eighty":39.188346,"marketCap":6190354389},{"date":"2023-06-09","current":40.98604,"twenty":10.659474,"median":23.193053,"eighty":39.394311,"marketCap":6301070880},{"date":"2023-06-16","current":40.456505,"twenty":10.636307,"median":23.23296,"eighty":39.77769,"marketCap":6219661695},{"date":"2023-06-22","current":40.265872,"twenty":10.614439,"median":23.277876,"eighty":40.236218,"marketCap":6190354389},{"date":"2023-06-26","current":42.066293,"twenty":10.603505,"median":23.311527,"eighty":40.265872,"marketCap":6467145616},{"date":"2023-07-07","current":40.943677,"twenty":10.600095,"median":23.213305,"eighty":40.520035,"marketCap":6294558145},{"date":"2023-07-14","current":40.98604,"twenty":10.600095,"median":23.213305,"eighty":40.545455,"marketCap":6301070880},{"date":"2023-07-21","current":42.087474,"twenty":10.600095,"median":23.213305,"eighty":40.680159,"marketCap":6470401984},{"date":"2023-07-28","current":41.515576,"twenty":10.600095,"median":23.213305,"eighty":40.924511,"marketCap":6382480064},{"date":"2023-08-04","current":40.24272,"twenty":10.600095,"median":23.354574,"eighty":40.932036,"marketCap":6609585096},{"date":"2023-08-11","current":40.998725,"twenty":10.600095,"median":23.481924,"eighty":40.941559,"marketCap":6733753602},{"date":"2023-08-18","current":40.707954,"twenty":10.600095,"median":23.579987,"eighty":40.983764,"marketCap":6685996485},{"date":"2023-08-25","current":42.161809,"twenty":10.600095,"median":23.703849,"eighty":41.024602,"marketCap":6924782073},{"date":"2023-09-01","current":43.402433,"twenty":10.600095,"median":23.784876,"eighty":41.205168,"marketCap":7128545776},{"date":"2023-09-08","current":42.685197,"twenty":10.600095,"median":23.881479,"eighty":41.417849,"marketCap":7010744885},{"date":"2023-09-15","current":43.169816,"twenty":10.600095,"median":23.959006,"eighty":41.704282,"marketCap":7090340081},{"date":"2023-09-22","current":41.832269,"twenty":10.600095,"median":24.063445,"eighty":41.742049,"marketCap":6870657340},{"date":"2023-09-29","current":43.402433,"twenty":10.600095,"median":24.159779,"eighty":41.859163,"marketCap":7128545776},{"date":"2023-10-06","current":42.917814,"twenty":10.600095,"median":24.411169,"eighty":41.925256,"marketCap":7048950579},{"date":"2023-10-13","current":41.173188,"twenty":10.600095,"median":24.472259,"eighty":41.970666,"marketCap":6762407873},{"date":"2023-10-20","current":40.378413,"twenty":10.600095,"median":24.601456,"eighty":42.032402,"marketCap":6631871751},{"date":"2023-10-27","current":40.688569,"twenty":10.590509,"median":24.763289,"eighty":42.053584,"marketCap":6682812677},{"date":"2023-11-03","current":67.987802,"twenty":10.590509,"median":24.82708,"eighty":42.104419,"marketCap":6259908894},{"date":"2023-11-10","current":70.993721,"twenty":10.590509,"median":24.916894,"eighty":42.169563,"marketCap":6536675855},{"date":"2023-11-17","current":70.858623,"twenty":10.590509,"median":25.114925,"eighty":42.251018,"marketCap":6524236890},{"date":"2023-11-24","current":73.222829,"twenty":10.590509,"median":25.234082,"eighty":42.431195,"marketCap":6741918769},{"date":"2023-12-01","current":73.661896,"twenty":10.590509,"median":25.380185,"eighty":42.822269,"marketCap":6782345404},{"date":"2023-12-08","current":74.269835,"twenty":10.594875,"median":25.475549,"eighty":42.99923,"marketCap":6838320744},{"date":"2023-12-15","current":78.728051,"twenty":10.594875,"median":25.683605,"eighty":43.169816,"marketCap":7248806574},{"date":"2023-12-22","current":79.302215,"twenty":10.594875,"median":25.809174,"eighty":43.432834,"marketCap":7301672173},{"date":"2023-12-29","current":81.497549,"twenty":10.590509,"median":25.871438,"eighty":43.801759,"marketCap":7503805346},{"date":"2024-01-05","current":79.741282,"twenty":10.586142,"median":26.026128,"eighty":45.173557,"marketCap":7342098807},{"date":"2024-01-12","current":75.688358,"twenty":10.586142,"median":26.123266,"eighty":45.499837,"marketCap":6968929872},{"date":"2024-01-19","current":75.215517,"twenty":10.581776,"median":26.310309,"eighty":46.429737,"marketCap":6925393496},{"date":"2024-01-26","current":74.607578,"twenty":10.586142,"median":26.757641,"eighty":47.070063,"marketCap":6869418156},{"date":"2024-02-02","current":73.45925,"twenty":10.586142,"median":26.8819,"eighty":48.970648,"marketCap":6763686957},{"date":"2024-02-09","current":29.434352,"twenty":10.586142,"median":27.133306,"eighty":50.736642,"marketCap":6115428204},{"date":"2024-02-16","current":30.047264,"twenty":10.666299,"median":27.737543,"eighty":50.736642,"marketCap":6242769792},{"date":"2024-02-23","current":30.222382,"twenty":10.755729,"median":28.081886,"eighty":50.736642,"marketCap":6279153103},{"date":"2024-03-01","current":31.958965,"twenty":12.580654,"median":28.465994,"eighty":50.389968,"marketCap":6639954272},{"date":"2024-03-08","current":32.236234,"twenty":14.477572,"median":28.687196,"eighty":50.389968,"marketCap":6697561181},{"date":"2024-03-15","current":32.995077,"twenty":15.693391,"median":29.087177,"eighty":50.389968,"marketCap":6855222195},{"date":"2024-03-22","current":34.906778,"twenty":16.21505,"median":29.378454,"eighty":50.389968,"marketCap":7252406675},{"date":"2024-03-28","current":34.819219,"twenty":16.431775,"median":29.448945,"eighty":50.389968,"marketCap":7234215019},{"date":"2024-04-05","current":34.279273,"twenty":16.579951,"median":29.605173,"eighty":50.736642,"marketCap":7122033143},{"date":"2024-04-12","current":33.05345,"twenty":16.813772,"median":29.772048,"eighty":50.736642,"marketCap":6867349966},{"date":"2024-04-19","current":31.911299,"twenty":16.916749,"median":30.058488,"eighty":50.736642,"marketCap":6630050987},{"date":"2024-04-26","current":33.386966,"twenty":17.091652,"median":30.249439,"eighty":50.389968,"marketCap":6936642941},{"date":"2024-05-03","current":31.422916,"twenty":17.176551,"median":30.506341,"eighty":50.389968,"marketCap":6443394612},{"date":"2024-05-10","current":30.911512,"twenty":17.328629,"median":30.882901,"eighty":50.389968,"marketCap":6338529239},{"date":"2024-05-17","current":30.158612,"twenty":17.488992,"median":30.882901,"eighty":50.389968,"marketCap":6184144105},{"date":"2024-05-24","current":28.993748,"twenty":17.580284,"median":30.882901,"eighty":50.389968,"marketCap":5945284088},{"date":"2024-05-31","current":30.812073,"twenty":17.615936,"median":30.882901,"eighty":50.389968,"marketCap":6318138749},{"date":"2024-06-07","current":31.08198,"twenty":17.668364,"median":30.954522,"eighty":50.389968,"marketCap":6373484363},{"date":"2024-06-14","current":30.883101,"twenty":17.731278,"median":31.025137,"eighty":50.389968,"marketCap":6332703384},{"date":"2024-06-21","current":31.536561,"twenty":17.769898,"median":31.042917,"eighty":50.736642,"marketCap":6466698028},{"date":"2024-06-28","current":31.920114,"twenty":17.8613,"median":31.103323,"eighty":50.736642,"marketCap":6545347058},{"date":"2024-07-05","current":31.394505,"twenty":18.024877,"median":31.149457,"eighty":50.736642,"marketCap":6437568758},{"date":"2024-07-12","current":31.820674,"twenty":18.175107,"median":31.199278,"eighty":50.736642,"marketCap":6524956569},{"date":"2024-07-19","current":32.104788,"twenty":18.272126,"median":31.292005,"eighty":50.736642,"marketCap":6583215110},{"date":"2024-07-26","current":33.227035,"twenty":18.414252,"median":31.360962,"eighty":50.736642,"marketCap":6813336346},{"date":"2024-08-02","current":34.335076,"twenty":18.480333,"median":31.430019,"eighty":50.736642,"marketCap":7040544655},{"date":"2024-08-09","current":21.981185,"twenty":18.723299,"median":31.444483,"eighty":50.736642,"marketCap":7693239023},{"date":"2024-08-16","current":21.475871,"twenty":18.914042,"median":31.444483,"eighty":50.736642,"marketCap":7516382953},{"date":"2024-08-23","current":21.09281,"twenty":19.069994,"median":31.444483,"eighty":50.736642,"marketCap":7382314643},{"date":"2024-08-30","current":21.215063,"twenty":19.173593,"median":31.444483,"eighty":50.736642,"marketCap":7425102401},{"date":"2024-09-06","current":20.497842,"twenty":19.271067,"median":31.444483,"eighty":50.736642,"marketCap":7174080883},{"date":"2024-09-13","current":21.565523,"twenty":19.391482,"median":31.444483,"eighty":50.736642,"marketCap":7547760643},{"date":"2024-09-20","current":21.532922,"twenty":19.566201,"median":31.444483,"eighty":50.736642,"marketCap":7536350574},{"date":"2024-09-27","current":21.158012,"twenty":19.756599,"median":31.444483,"eighty":50.736642,"marketCap":7405134781},{"date":"2024-10-04","current":21.728528,"twenty":20.051881,"median":31.444483,"eighty":50.736642,"marketCap":7604810988},{"date":"2024-10-11","current":21.378068,"twenty":20.260356,"median":31.444483,"eighty":50.736642,"marketCap":7482152746},{"date":"2024-10-18","current":23.554181,"twenty":20.577253,"median":31.444483,"eighty":50.736642,"marketCap":8243774852},{"date":"2024-10-25","current":22.714707,"twenty":20.830566,"median":31.444483,"eighty":50.736642,"marketCap":7949965575},{"date":"2024-11-01","current":20.868399,"twenty":20.870141,"median":31.444483,"eighty":50.736642,"marketCap":9743956162},{"date":"2024-11-08","current":22.171145,"twenty":20.970556,"median":31.444483,"eighty":50.736642,"marketCap":10352239475},{"date":"2024-11-15","current":21.070232,"twenty":21.016922,"median":31.444483,"eighty":50.736642,"marketCap":9838197239},{"date":"2024-11-22","current":21.779709,"twenty":21.079263,"median":31.444483,"eighty":50.736642,"marketCap":10169468902},{"date":"2024-11-29","current":22.299584,"twenty":21.136314,"median":31.444483,"eighty":50.736642,"marketCap":10412211069},{"date":"2024-12-06","current":21.908149,"twenty":21.209839,"median":31.444483,"eighty":50.736642,"marketCap":10229440496},{"date":"2024-12-13","current":21.424971,"twenty":21.270039,"median":31.444483,"eighty":50.736642,"marketCap":10003833070},{"date":"2024-12-20","current":20.360756,"twenty":21.286762,"median":31.444483,"eighty":50.736642,"marketCap":9506925575},{"date":"2024-12-27","current":20.678797,"twenty":21.286762,"median":31.444483,"eighty":50.736642,"marketCap":9655426666},{"date":"2025-01-03","current":20.776656,"twenty":21.286762,"median":31.444483,"eighty":50.736642,"marketCap":9701119309},{"date":"2025-01-10","current":22.030472,"twenty":21.317067,"median":31.451844,"eighty":51.083315,"marketCap":10286556300},{"date":"2025-01-17","current":22.140564,"twenty":21.392738,"median":31.451844,"eighty":51.083315,"marketCap":10337960524},{"date":"2025-01-24","current":19.804184,"twenty":21.420049,"median":31.451844,"eighty":51.083315,"marketCap":9247048667},{"date":"2025-01-31","current":20.275129,"twenty":21.420049,"median":31.451844,"eighty":51.083315,"marketCap":9466944513},{"date":"2025-02-07","current":20.476963,"twenty":21.420049,"median":31.451844,"eighty":51.083315,"marketCap":9561185589},{"date":"2025-02-14","current":18.792386,"twenty":21.420049,"median":31.451844,"eighty":51.083315,"marketCap":9795850750},{"date":"2025-02-21","current":19.785698,"twenty":21.420049,"median":31.451844,"eighty":51.083315,"marketCap":10313631432},{"date":"2025-02-28","current":20.773641,"twenty":21.420049,"median":31.451844,"eighty":51.083315,"marketCap":10828613300},{"date":"2025-03-07","current":20.714579,"twenty":21.424971,"median":31.451844,"eighty":51.429988,"marketCap":10797826341},{"date":"2025-03-14","current":19.678313,"twenty":21.424971,"median":31.451844,"eighty":51.429988,"marketCap":10257655142},{"date":"2025-03-21","current":19.84476,"twenty":21.424971,"median":31.451844,"eighty":51.429988,"marketCap":10344418392},{"date":"2025-03-28","current":19.705159,"twenty":21.424971,"median":31.451844,"eighty":51.429988,"marketCap":10271649215},{"date":"2025-04-04","current":18.561508,"twenty":21.424971,"median":31.451844,"eighty":51.429988,"marketCap":9675501726},{"date":"2025-04-11","current":18.958833,"twenty":21.420049,"median":31.451844,"eighty":51.083315,"marketCap":9882613999},{"date":"2025-04-17","current":19.324707,"twenty":21.420049,"median":31.451844,"eighty":51.083315,"marketCap":10073332113},{"date":"2025-04-25","current":19.986841,"twenty":21.378068,"median":31.451844,"eighty":51.429988,"marketCap":10418480823},{"date":"2025-05-02","current":21.145576,"twenty":21.26595,"median":31.451844,"eighty":51.429988,"marketCap":11022491066},{"date":"2025-05-09","current":19.314028,"twenty":21.215063,"median":31.451844,"eighty":51.429988,"marketCap":10067765198},{"date":"2025-05-16","current":19.238052,"twenty":21.149861,"median":31.451844,"eighty":51.429988,"marketCap":12380955912},{"date":"2025-05-23","current":18.161738,"twenty":21.100813,"median":31.451844,"eighty":51.429988,"marketCap":11688276880},{"date":"2025-05-30","current":18.051564,"twenty":21.052058,"median":31.451844,"eighty":51.429988,"marketCap":11617372728},{"date":"2025-06-06","current":17.954102,"twenty":21.011307,"median":31.451844,"eighty":51.429988,"marketCap":11554649823},{"date":"2025-06-13","current":17.704092,"twenty":20.970556,"median":31.451844,"eighty":51.429988,"marketCap":11393751938},{"date":"2025-06-20","current":17.263397,"twenty":20.919812,"median":31.451844,"eighty":52.534404,"marketCap":11110135327},{"date":"2025-06-27","current":18.259199,"twenty":20.836957,"median":31.451844,"eighty":52.534404,"marketCap":11750999785},{"date":"2025-07-03","current":19.555861,"twenty":20.776053,"median":31.451844,"eighty":52.534404,"marketCap":12585487122},{"date":"2025-07-11","current":19.14059,"twenty":20.723755,"median":31.451844,"eighty":52.534404,"marketCap":12318233007},{"date":"2025-07-18","current":19.013466,"twenty":20.683176,"median":31.451844,"eighty":52.534404,"marketCap":12236420523},{"date":"2025-07-25","current":18.979567,"twenty":20.586623,"median":31.451844,"eighty":52.534404,"marketCap":12214603861},{"date":"2025-08-01","current":16.188856,"twenty":20.513914,"median":31.451844,"eighty":52.534404,"marketCap":9750515310},{"date":"2025-08-08","current":16.711798,"twenty":20.476963,"median":31.451844,"eighty":52.534404,"marketCap":10065482260},{"date":"2025-08-15","current":17.194513,"twenty":20.30571,"median":31.451844,"eighty":52.534404,"marketCap":10356220982},{"date":"2025-08-22","current":17.301783,"twenty":20.251749,"median":31.451844,"eighty":52.534404,"marketCap":10420829587},{"date":"2025-08-29","current":16.939747,"twenty":20.21434,"median":31.451844,"eighty":52.534404,"marketCap":10202775545},{"date":"2025-09-05","current":16.707328,"twenty":20.146713,"median":31.458689,"eighty":53.63882,"marketCap":10062790234},{"date":"2025-09-12","current":17.462689,"twenty":19.984406,"median":31.451844,"eighty":52.534404,"marketCap":10517742495},{"date":"2025-09-19","current":18.079492,"twenty":19.948593,"median":31.451844,"eighty":52.534404,"marketCap":10889241974},{"date":"2025-09-26","current":17.292844,"twenty":19.877101,"median":31.451844,"eighty":52.534404,"marketCap":10415445537},{"date":"2025-10-03","current":18.481755,"twenty":19.840807,"median":31.451844,"eighty":52.534404,"marketCap":11131524243},{"date":"2025-10-10","current":17.239209,"twenty":19.803707,"median":31.451844,"eighty":52.534404,"marketCap":10383141234},{"date":"2025-10-17","current":17.525263,"twenty":19.742534,"median":31.451844,"eighty":52.534404,"marketCap":10555430848},{"date":"2025-10-24","current":17.006791,"twenty":19.679289,"median":31.451844,"eighty":52.534404,"marketCap":10243155924},{"date":"2025-10-31","current":17.404584,"twenty":19.615895,"median":31.451844,"eighty":52.534404,"marketCap":10482746167},{"date":"2025-11-07","current":16.202116,"twenty":19.555861,"median":31.437122,"eighty":52.534404,"marketCap":10983462856},{"date":"2025-11-14","current":16.817637,"twenty":19.509455,"median":31.380299,"eighty":52.534404,"marketCap":11400726764},{"date":"2025-11-21","current":16.591284,"twenty":19.373439,"median":31.295065,"eighty":52.534404,"marketCap":11247281327},{"date":"2025-11-28","current":17.540379,"twenty":19.314266,"median":31.202932,"eighty":52.534404,"marketCap":11890675352},{"date":"2025-12-05","current":17.619801,"twenty":19.287595,"median":31.161149,"eighty":52.534404,"marketCap":11944515856},{"date":"2025-12-12","current":16.436411,"twenty":19.234266,"median":31.110391,"eighty":52.534404,"marketCap":11142292344},{"date":"2025-12-19","current":16.905002,"twenty":19.13508,"median":31.060696,"eighty":52.534404,"marketCap":11459951318},{"date":"2025-12-26","current":18.469618,"twenty":19.091517,"median":30.989578,"eighty":52.534404,"marketCap":12520609251},{"date":"2026-01-02","current":17.405361,"twenty":19.012619,"median":30.926871,"eighty":52.534404,"marketCap":11799146495},{"date":"2026-01-09","current":17.532437,"twenty":18.97458,"median":30.882901,"eighty":52.534404,"marketCap":11885291302},{"date":"2026-01-16","current":18.044709,"twenty":18.899845,"median":30.670016,"eighty":50.234126,"marketCap":12232562554},{"date":"2026-01-23","current":17.671425,"twenty":18.838561,"median":30.491754,"eighty":50.234126,"marketCap":11979512184},{"date":"2026-01-30","current":16.78984,"twenty":18.766673,"median":30.249439,"eighty":50.234126,"marketCap":11381882587},{"date":"2026-02-06","current":16.825579,"twenty":18.695068,"median":30.105636,"eighty":50.234126,"marketCap":11406110814},{"date":"2026-02-13","current":14.170695,"twenty":18.554438,"median":29.889985,"eighty":43.40631,"marketCap":11089561020},{"date":"2026-02-20","current":14.65522,"twenty":18.504467,"median":29.831882,"eighty":43.092277,"marketCap":11468735706},{"date":"2026-02-27","current":14.695044,"twenty":18.475686,"median":29.755401,"eighty":42.964338,"marketCap":11499900748},{"date":"2026-03-06","current":13.699445,"twenty":18.456655,"median":29.521911,"eighty":42.638674,"marketCap":10720774681},{"date":"2026-03-13","current":13.66294,"twenty":18.41075,"median":29.44758,"eighty":42.285872,"marketCap":10692206726},{"date":"2026-03-16","current":13.68617,"twenty":18.397459,"median":29.434352,"eighty":42.231595,"marketCap":10710386334}],"updateTime":1773742264462},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"EXEL\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2602683675","title":"Exelixis forecasts 2026 net product revenues of $2.325 billion to $2.425 billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2602683675","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602683675?lang=en_us&edition=fundamental","pubTime":"2026-01-12 05:00","pubTimestamp":1768165222,"startTime":"0","endTime":"0","summary":"Exelixis Inc. has announced its preliminary unaudited financial results for fiscal year 2025, reporting approximately $2.123 billion in U.S. net product revenues from its cabozantinib franchise. Looking ahead, the company has provided financial guidance for fiscal year 2026, forecasting net product revenues in the range of $2.325 billion to $2.425 billion. This outlook reflects a significant expected increase in revenues, underscoring the company’s strong commercial momentum and the anticipated growth of its oncology portfolio.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Exelixis Inc. published the original content used to generate this news brief via Business Wire  on January 11, 2026, and is solely responsible for the information ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260111:nNDLcfbMJz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EXEL","BK4532","BK4139"],"gpt_icon":0},{"id":"2602556834","title":"Exelixis Inc: Fiscal Year 2026 Net Product Revenues Guidance of $2.325 Billion - $2.425 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2602556834","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602556834?lang=en_us&edition=fundamental","pubTime":"2026-01-12 05:00","pubTimestamp":1768165202,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260111:nTUA8BPWKW:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4532","EXEL","BK4139"],"gpt_icon":0},{"id":"2602530713","title":"A Look At Exelixis (EXEL) Valuation After Zanzalintinib Phase 3 Success And New STELLAR-316 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2602530713","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602530713?lang=en_us&edition=fundamental","pubTime":"2026-01-10 06:28","pubTimestamp":1767997690,"startTime":"0","endTime":"0","summary":"Exelixis (EXEL) is back in focus after reporting strong phase 3 data for zanzalintinib in metastatic colorectal cancer, alongside launching the Natera partnership for the planned STELLAR-316 pivotal trial in earlier stage disease.\nSee our latest analysis for Exelixis.\nThe recent phase 3 readout for zanzalintinib and the planned STELLAR-316 trial come after a strong run in the shares, with a 90 day share price return of 15.44% and a 1 year total shareholder return of 22.27%. The 3 year total...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/28338-main-header/1585188087119","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/28338-main-header/1585188087119"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-exel/exelixis/news/a-look-at-exelixis-exel-valuation-after-zanzalintinib-phase","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-exel/exelixis/news/a-look-at-exelixis-exel-valuation-after-zanzalintinib-phase","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4532","EXEL","BK4139"],"gpt_icon":0},{"id":"2602304439","title":"Signet Jewelers, Natural Gas Services, and More Stocks See Action From Activist Investors -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2602304439","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602304439?lang=en_us&edition=fundamental","pubTime":"2026-01-10 06:18","pubTimestamp":1767997080,"startTime":"0","endTime":"0","summary":"These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity's attaining more than 5% in any class of a company's securities. Subsequent changes in holdings or intentions must be reported in amended filings. This material is from Jan. 1 through Jan. 7, 2026. Source: VerityData. Middleby  Garden Investment Management raised its stake in the food-service equipment maker to 3,379,737 shares. Garden Investment Management did so through the purchase of 102,903 Middleby shares from Dec. 11 through Dec. 15 at per share prices ranging from $142.92 to $147.Exelixis  Farallon Capital Management lowered its stake in the biopharmaceutical company to 15,709,500 shares. Farallon Capital did so through the sale of 4,169,000 Exelixis shares from Nov. 13 through Dec. 15 at per share prices ranging from $40.77 to $44.50, and partially offset those sales through the purchase of 168,000 shares from Nov. 10 through Dec. 31 at $40.32 to $43.90","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4200","LU1721429402.USD","BK4139","ISBC","MIDD","LU2211817866.USD","EXEL","BK4161","BK4023","EGHT","BK4211","BK4532","NGS","LU1721429741.USD","BK4179","SIG","LU1878469433.USD"],"gpt_icon":0},{"id":"2602720397","title":"Exelixis Shares Fall After Downgrade From Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2602720397","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602720397?lang=en_us&edition=fundamental","pubTime":"2026-01-09 03:51","pubTimestamp":1767901908,"startTime":"0","endTime":"0","summary":"Exelixis  shares were down more than 5% in recent Thursday trading after Morgan Stanley downgraded the biotechnology company's stock to equalweight, with a price target of $48.Trading volume stood at nearly 1.5 million shares, compared with a daily average of 2.8 million.Price: 43.71, Change: -2.48, Percent Change: -5.37","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EXEL"],"gpt_icon":0},{"id":"2602995443","title":"Exelixis Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2602995443","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602995443?lang=en_us&edition=fundamental","pubTime":"2026-01-09 00:48","pubTimestamp":1767890880,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/EXEL/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 08, 2026 11:48 ET (16:48 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EXEL"],"gpt_icon":0},{"id":"2601398411","title":"Exelixis price target raised to $52 from $49 at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2601398411","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601398411?lang=en_us&edition=fundamental","pubTime":"2026-01-08 22:35","pubTimestamp":1767882949,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Robert Burns raised the firm’s price target on Exelixis (EXEL) to $52 from $49 and keeps a Buy rating on the shares after t...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/exelixis-price-target-raised-to-52-from-49-at-h-c-wainwright-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/exelixis-price-target-raised-to-52-from-49-at-h-c-wainwright-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EXEL"],"gpt_icon":0},{"id":"2601360210","title":"Exelixis, Inc. : H.c. Wainwright Raises Target Price to $52 From $49","url":"https://stock-news.laohu8.com/highlight/detail?id=2601360210","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601360210?lang=en_us&edition=fundamental","pubTime":"2026-01-08 22:23","pubTimestamp":1767882215,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nAZN4RSH19:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EXEL","BK4139","BK4532"],"gpt_icon":0},{"id":"2601619033","title":"Morgan Stanley Downgrades Exelixis to Equalweight, Price Target is $48","url":"https://stock-news.laohu8.com/highlight/detail?id=2601619033","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601619033?lang=en_us&edition=fundamental","pubTime":"2026-01-08 20:47","pubTimestamp":1767876445,"startTime":"0","endTime":"0","summary":"Exelixis (EXEL) has an average rating of overweight and mean price target of $45.33, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ban","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EXEL"],"gpt_icon":0},{"id":"2601727369","title":"Exelixis Cut to Equal-Weight From Overweight by Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2601727369","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601727369?lang=en_us&edition=fundamental","pubTime":"2026-01-08 20:28","pubTimestamp":1767875280,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/EXEL/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 08, 2026 07:28 ET (12:28 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EXEL"],"gpt_icon":0},{"id":"2601809819","title":"BRIEF-Exelixis And Natera To Collaborate On Stellar-316, A Phase 3 Pivotal Trial Of Zanzalintinib","url":"https://stock-news.laohu8.com/highlight/detail?id=2601809819","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601809819?lang=en_us&edition=fundamental","pubTime":"2026-01-07 22:07","pubTimestamp":1767794860,"startTime":"0","endTime":"0","summary":"BRIEF-Exelixis And Natera To Collaborate On Stellar-316, A Phase 3 Pivotal Trial Of Zanzalintinib Jan 7 (Reuters) - Exelixis Inc EXEL.O:EXELIXIS AND NATERA TO COLLABORATE ON STELLAR-316, A PHASE 3 PIV","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260107:nTUA8SKRRS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU1064131342.USD","LU2065731478.USD","LU2065169927.USD","LU2065171311.SGD","LU0345770308.USD","LU0106261612.USD","LU0053671581.USD","LU1988902786.USD","BK4532","LU0963586101.USD","NTRA","LU0012050646.USD","LU2065171402.SGD","LU2324357040.USD","LU2065170008.USD","LU0345770993.USD","LU2264538146.SGD","EXEL"],"gpt_icon":0},{"id":"2601803138","title":"Exelixis and Natera Announce Collaboration on Phase 3 Colorectal Cancer Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2601803138","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601803138?lang=en_us&edition=fundamental","pubTime":"2026-01-07 21:01","pubTimestamp":1767790912,"startTime":"0","endTime":"0","summary":"Exelixis Inc. has announced a collaboration with Natera to conduct the STELLAR-316 Phase 3 pivotal trial, which will evaluate Exelixis' oral kinase inhibitor, zanzalintinib, with and without an immune checkpoint inhibitor in patients with resected stage II/III colorectal cancer. Natera's Signatera test will be used to identify patients with molecular residual disease  and for ongoing monitoring of circulating tumor DNA clearance throughout the trial. Exelixis expects to initiate enrollment for the STELLAR-316 trial in mid-2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Exelixis Inc. published the original content used to generate this news brief via Business Wire  on January 07, 2026, and is solely responsible for the information ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260107:nNDL1XV8vK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0106261612.USD","LU2065169927.USD","LU2065171402.SGD","LU2264538146.SGD","LU0012050646.USD","LU2324357040.USD","LU0345770993.USD","LU0053671581.USD","BK4532","LU1064131342.USD","LU2065170008.USD","LU0345770308.USD","LU1988902786.USD","LU0963586101.USD","NTRA","LU2065731478.USD","EXEL","LU2065171311.SGD","BK4139"],"gpt_icon":0},{"id":"2601965803","title":"Exelixis Inc - Expects to Initiate Stellar-316 in Mid-2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2601965803","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601965803?lang=en_us&edition=fundamental","pubTime":"2026-01-07 21:00","pubTimestamp":1767790803,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260107:nTUA8SKRRS:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2065170008.USD","LU1988902786.USD","EXEL","LU0963586101.USD","LU2065731478.USD","LU2065171311.SGD","LU2324357040.USD","LU0106261612.USD","LU2065171402.SGD","LU2264538146.SGD","NTRA","LU1064131342.USD","BK4139","LU0053671581.USD","LU0345770308.USD","LU0012050646.USD","LU2065169927.USD","BK4532","LU0345770993.USD"],"gpt_icon":0},{"id":"2601803604","title":"Exelixis and Natera to Collaborate on Stellar-316, a Phase 3 Pivotal Trial of Zanzalintinib for Patients With Colorectal Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2601803604","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601803604?lang=en_us&edition=fundamental","pubTime":"2026-01-07 21:00","pubTimestamp":1767790803,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260107:nTUA8SKRRS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2065170008.USD","LU1988902786.USD","EXEL","LU0963586101.USD","LU2065731478.USD","LU2065171311.SGD","LU2324357040.USD","LU0106261612.USD","LU2065171402.SGD","LU2264538146.SGD","NTRA","LU1064131342.USD","BK4139","LU0053671581.USD","LU0345770308.USD","LU0012050646.USD","LU2065169927.USD","BK4532","LU0345770993.USD"],"gpt_icon":0},{"id":"2601848722","title":"Exelixis CEO to Present Corporate Overview at J.P. Morgan Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2601848722","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601848722?lang=en_us&edition=fundamental","pubTime":"2026-01-07 05:05","pubTimestamp":1767733526,"startTime":"0","endTime":"0","summary":"Exelixis Inc. will present a corporate overview at the J.P. Morgan 2026 Healthcare Conference on January 12, 2026. Michael M. Morrissey, Ph.D., the company's President and CEO, will lead the presentation, which will be webcast on the Exelixis website.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Exelixis Inc. published the original content used to generate this news brief via Business Wire  on January 06, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260106:nNDL3hBtyy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","EXEL","BK4532"],"gpt_icon":0},{"id":"2601835569","title":"Exelixis Faces Limited High-Impact Catalysts, BofA Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2601835569","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601835569?lang=en_us&edition=fundamental","pubTime":"2026-01-06 00:43","pubTimestamp":1767631396,"startTime":"0","endTime":"0","summary":"Exelixis  faces limited high-impact catalysts, and the opportunity from potential success with the zanza trials is already priced into the valuation, BofA Securities said in a Monday note.Analysts said that the company's Cabometyx cancer drug has limited patent life, with exclusivity set to expire by 2031.BofA said that since phase 3 data from its trial evaluating zanza in colorectal cancer was \"relatively underwhelming,\" it expects only niche peak sales of around $300 million.Analysts said that updates from competitors could weigh on Exelixis shares, notably from Merck , which could erode Cabometyx's market position.BofA downgraded the stock's rating to underperform from neutral and lowered its price target to $41 from $43.Exelixis shares were down 3% in recent Monday trading.Price: 42.12, Change: -1.46, Percent Change: -3.35","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0477156953.USD","SGXZ57979304.SGD","LU1585245621.USD","LU1201861249.SGD","LU1571399168.USD","BK4534","LU2106854487.HKD","LU0130102774.USD","BK4532","SG9999014559.SGD","SG9999015341.SGD","IE00B2B36J28.USD","LU1989772923.USD","LU0965509101.SGD","LU1057294990.SGD","BK4559","LU2360032135.SGD","SG9999014542.SGD","LU0265550359.USD","LU0965508806.USD","EXEL","LU1093756168.USD","LU0208291251.USD","LU1093756325.SGD","IE00BFTCPJ56.SGD","LU0238689110.USD","IE000M9KFDE8.USD","LU1989771016.USD","SG9999014567.USD","BK4550","LU0130517989.USD","SG9999002224.SGD","LU2324357040.USD","LU1941712264.USD","LU0070302665.USD","LU0098860793.USD","LU0203345920.USD","LU1066053197.SGD","BK4007","LU1974910355.USD","BK4533","LU1066051225.USD","IE00BLSP4239.USD","LU0289739699.SGD","LU1699723380.USD","LU1066051498.USD","LU1069347547.HKD","LU2023250504.SGD","LU1291159041.SGD","BK4585","BK4139","LU2023250843.SGD","LU0965509010.AUD","SG9999014575.USD","LU0006306889.USD","LU1917777945.USD","LU0122379950.USD","IE00BN8TJ469.HKD","IE00B4R5TH58.HKD","LU1037948897.HKD","LU1934455277.USD","LU1934455194.USD","LU0648001328.SGD","BK4588","LU0211331839.USD","LU2361044949.HKD","LU0058720904.USD","LU1035773651.USD","LU1934455863.HKD","LU2125154778.USD","IE00BSNM7G36.USD","LU1162221912.USD","LU0106261372.USD","LU2461242641.AUD","SG9999002232.USD","LU0203347892.USD","IE00BJT1NW94.SGD","LU0265550946.USD","LU1066051811.HKD","LU1116320737.USD","LU2112291526.USD","LU1116320901.HKD","LU0985320562.USD","SG9999013999.USD","LU1941712348.USD","IE0002141913.USD","LU0980610538.SGD","IE00B1BXHZ80.USD","LU0965509283.SGD","LU2089984988.USD","LU1983299246.USD","LU1037948541.HKD","LU2125154935.USD","SG9999015358.SGD","SG9999001440.SGD","LU2361044865.SGD","LU0266013472.USD","LU1989772840.SGD","LU0320765646.SGD","BK4516","SG9999001176.USD","LU1023059063.AUD","IE00BBT3K403.USD","IE00BJJMRZ35.SGD","LU0320765489.SGD","LU1430594728.SGD","LU1929549753.HKD","LU0861579265.USD","LU2468319806.SGD","LU1061106388.HKD","SG9999001176.SGD","LU2361045086.USD","IE0009355771.USD","LU0234572021.USD","IE00BLSP4452.SGD"],"gpt_icon":0},{"id":"2601880794","title":"BofA Securities Downgrades Exelixis to Underperform From Neutral, Adjusts Price Target to $41 From $43","url":"https://stock-news.laohu8.com/highlight/detail?id=2601880794","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601880794?lang=en_us&edition=fundamental","pubTime":"2026-01-05 23:06","pubTimestamp":1767625607,"startTime":"0","endTime":"0","summary":"Exelixis (EXEL) has an average rating of overweight and mean price target of $45.17, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ban","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EXEL"],"gpt_icon":0},{"id":"2588502140","title":"Exelixis Webcasts Virtual 2025 R&D Day to Showcase Oncology Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2588502140","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588502140?lang=en_us&edition=fundamental","pubTime":"2025-12-04 05:05","pubTimestamp":1764795959,"startTime":"0","endTime":"0","summary":"Exelixis Inc. will host a virtual 2025 Research & Development (R&D) Day on Wednesday, December 10, 2025, from 1:00 p.m. to 3:30 p.m. EST. The event, titled \"Building Next-generation Oncology Franchises,\" will feature speakers reviewing the company's R&D progress and outlining strategies to advance future oncology franchises. A live webcast and a recording of the event will be available at EXELRDDay.com and on the Exelixis website, remaining accessible for one year. Participants are encouraged to register in advance using the code EXELR&D.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Exelixis Inc. published the original content used to generate this news brief via Business Wire  on December 03, 2025, and is solely responsible for the ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251203:nNDL1sYQDw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EXEL","BK4532","BK4139"],"gpt_icon":0},{"id":"2586981822","title":"Exelixis director buys $1.2M in common stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2586981822","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586981822?lang=en_us&edition=fundamental","pubTime":"2025-11-27 05:30","pubTimestamp":1764192622,"startTime":"0","endTime":"0","summary":"In a regulatory filing, Exelixis (EXEL) disclosed that its director David Johnson bought 27.5K shares of common stock on November 25th in a total t...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/exelixis-director-buys-1-2m-in-common-stock-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/exelixis-director-buys-1-2m-in-common-stock-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4532","EXEL"],"gpt_icon":0},{"id":"2586260137","title":"Exelixis Inc. Director David Edward Johnson Reports Acquisition of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2586260137","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586260137?lang=en_us&edition=fundamental","pubTime":"2025-11-27 05:06","pubTimestamp":1764191173,"startTime":"0","endTime":"0","summary":"David Edward Johnson, Director, reported the acquisition of common shares of Exelixis Inc. according to a recent SEC filing. The form was filed by more than one reporting person, including Johnson and other reporting beneficial owners. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Exelixis Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 26, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251126:nNDL4FW7NX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Exelixis Inc. Director David Edward Johnson Reports Acquisition of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EXEL","BK4139","BK4532"],"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":4,"totalSize":162,"code":"91000000","status":"200"}]}}